Everpar Advisors LLC Purchases New Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Everpar Advisors LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,992 shares of the healthcare conglomerate's stock, valued at approximately $1,049,000.

Other institutional investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 53,573.1% during the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate's stock valued at $1,238,515,000 after purchasing an additional 2,348,107 shares during the period. Jennison Associates LLC boosted its position in UnitedHealth Group by 49.3% in the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate's stock valued at $1,904,670,000 after buying an additional 1,195,352 shares during the last quarter. Mawer Investment Management Ltd. grew its stake in shares of UnitedHealth Group by 75.0% during the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate's stock valued at $1,014,002,000 after acquiring an additional 862,024 shares in the last quarter. California Public Employees Retirement System lifted its stake in shares of UnitedHealth Group by 35.9% in the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate's stock worth $1,627,311,000 after acquiring an additional 815,822 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in UnitedHealth Group by 20.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate's stock worth $1,879,245,000 after purchasing an additional 623,631 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $2.25 during trading hours on Wednesday, hitting $503.21. 2,922,430 shares of the stock were exchanged, compared to its average volume of 4,362,104. The firm has a market capitalization of $462.99 billion, a P/E ratio of 30.76, a P/E/G ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company's 50 day moving average is $481.45 and its 200 day moving average is $511.98.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts' consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group's dividend payout ratio is 45.97%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Truist Financial restated a "buy" rating and issued a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Morgan Stanley decreased their price target on UnitedHealth Group from $618.00 to $584.00 and set an "overweight" rating for the company in a research note on Friday, April 5th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a "buy" rating in a report on Friday, April 19th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating on the stock in a research report on Monday, April 8th. Finally, Oppenheimer reissued an "outperform" rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $570.05.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company's stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.